C25 D37.70 K86
Conditions
Interventions
Group 1: HEPARFLOW is a one-arm prospektive exploratory study. Included are patients intended for partial or total pancreatoduodenectomy. The focus will be on the intraoperative flow measurement via D
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients scheduled for partial or total pancreatoduodenectomy (open); Patients over 18 years; Written informed consent; Ability of subject to understand character and individual consequences of the clinical trial
Exclusion criteria
Exclusion criteria: Patients having previously received operations on upper gastrointestinal organs (esophageal resection, gastric surgery, splenectomy, liver resection of one or more segments, liver transplantation, pancreas left resection, vascular surgery of the visceral vessels); Liver cirrhosis and other severe liver disease; Bilirubin over 15 mg/dl
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Flow rates in the proper hepatic artery, gastroduodenal artery and other relevant vessels for the liver blood supply and their variations during pancreatoduodenectomy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complication rate based on variations of hepatic blood flow during pancreatic surgery. | — |
Countries
Germany
Contacts
Public ContactKlinisches Studienzentrum der Chirurgie (KSC)
Chirurgische Universitätsklinik Heidelberg
Outcome results
None listed